Company Ticker News November 30, 2021An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns 0 0 Share
Press Release November 30, 2021Merck and Ridgeback Statement on Positive FDA Advisory Committee Vote for Investigational Oral Antiviral Molnupiravir for Treatment of Mild to Moderate COVID-19 in High Risk Adults 0 0 Share
Company Ticker News November 30, 2021FDA panel narrowly moves to authorize Merck's COVID treatment pill 0 0 Share
Company Ticker News November 30, 2021Is A Rise Imminent For Merck Stock After An 8% Fall In A Month? 0 0 Share
Company Ticker News November 30, 2021FDA advisers to vote Tuesday on Merck's COVID-19 pill even as interest has waned 0 0 Share
Press Release November 29, 2021FDA's AdComm Meet Tomorrow To Review Safety, Efficacy of Merck's COVID-19 Pill 0 0 Share
Company Ticker News November 29, 2021Merck (MRK) COVID Pill Less Effective in Final Study, Stock Down 0 0 Share
Company Ticker News November 26, 2021Updated Data Shows Merck's Oral COVID-19 Antiviral Cuts Hospitalization, Death Risk By 30% 0 0 Share
Company Ticker News November 26, 2021Blue-Chip Drugmaker Falls on Newest Covid Treatment Data 0 0 Share
